Author:
Kuyama Shoichi,Hotta Katsuyuki,Tabata Masahiro,Segawa Yoshihiko,Fujiwara Yoshiro,Takigawa Nagio,Kiura Katsuyuki,Ueoka Hiroshi,Eguchi Kenji,Tanimoto Mitsune
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference23 articles.
1. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer;Furuse;J Clin Oncol,1999
2. Long-term benefit is observed in a phase III comparaison of sequential vs concurrent chemoradiation for patients with unresectable stage III NSCLC: RTOG 94-10;Curran;Proc Am Soc Clin Oncol,2003
3. HER2-targeted therapies in non-small cell lung cancer;Swanton;Clin Cancer Res,2006
4. Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations;Tsai;J Natl Cancer Inst,1993
5. Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene;Pietras;Cancer Res,1999
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献